Skip to main content

Advertisement

Log in

AMACR: an emerging diagnostic and prognostic tool in systemic malignancies

  • Urology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al-Maghrebi M, Kehinde EO, Anim JT, Sheikh M (2012) The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer. Int Urol Nephrol 44:1681–1689

    Article  PubMed  CAS  Google Scholar 

  2. Langner C, Rupar G, Leibl S et al (2006) Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 448:325–330

    Article  PubMed  CAS  Google Scholar 

  3. Guzman G, Wu SJ, Kajdacsy-Balla A, Cotler SJ (2006) Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes. Appl Immunohistochem Mol Morphol 14:411–416

    Article  PubMed  CAS  Google Scholar 

  4. Mroz A, Kiedrowski M, Lewandowski Z (2012) Alpha-methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival. Appl Immunohistochem Mol Morphol (in press)

  5. Marx A, Simon P, Simon R et al (2008) AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Arch 453:243–248

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shailendra Kapoor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapoor, S. AMACR: an emerging diagnostic and prognostic tool in systemic malignancies. Int Urol Nephrol 45, 439–440 (2013). https://doi.org/10.1007/s11255-013-0393-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-013-0393-3

Keywords

Navigation